They are trying to persuade to get approval from a different angle I don't know if that is right way or not, thus I'm not giving it any credit for now I wouldn't give credit for something which is pretty much unknown to me
But ATK did say it was "proven", so ask him instead
2. Biomarkers. For Aduhelm FDA was using reduction in amyloid deposits. For taurx case, rate of brain atrophy us being used. Rate of brain volume atrophy is the scientifically best measurement to prove drug efficacy because AD patients' brains will all shrink due to dying brain cells.
3. When pure placebo is unfeasible (as seen in taurx's case), use ADNI historical placebo patients' performance for all the previous clinical trials done. There is ready pool of data probably 10k of placebo patients for all the past decades of AD clinical trials
There is no way Taurx is able to do double-blinded trial patients due to harmless blue pee side effects for our clinical trials without causing Therapeutic Active Placebo (TAP).
************************************************************** ABLE TO REVERSE DISEASE PROGRESSION (MCI PATIENTS) **************************************************************
In the 105 participants with MCI (baseline MMSE score 23) receiving the 16 mg/day dose, there was statistically significant cognitive improvement of 2 units over the pre-treatment baseline at 6 months (p=0.0002), 12 months (p=0.0391) and 18 months (p=0.0473) on the ADAS-cog13 scale. The mean change on the instrumental activities of daily living subscale of ADCS-ADL also remained above the pre-treatment baseline at 6, 12 and 18 months.
************************************************************************** ABLE TO HALT DISEASE PROGRESSION (MILD & MODERATE PATIENTS) *************************************************************************** In the 147 participants with mild to moderate AD (baseline MMSE 20) receiving 16 mg/day, there was a 2.5 unit cognitive decline in the first 9 months and no further decline over the following 9 months. The functional decline on the ADCS-ADL scale was -2 units at 12 months and -3 units at 18 months representing a reduction in decline of about 75% relative to a published meta-analysis of publicly available placebo decline data from historical trials in mild to moderate AD
I believe I am a typical noob in medical Based on my understanding, one of the indicator is not showing good result (due to it being tainted) I think the critical question is whether any other drug was approved in the past even if that same indicator is not positive, or the indicator can still be clinically approved using a different indicator?
Well, few more reasons not to cheer, was the selling by LKT and son, at the peak of the previous "good news" As they say, fool me twice shame on me lol The other possible reduced reaction, is probably the impact can only be felt in FY2024, and many things can happen in between
MoneyMakers, to be fair, "cannot differentiate test vs placebo", is not in the performance sense I just did a short crash course on "placebo effect" and "active placebo" via google You need to understand the proper placebo purpose and the placebo effect to understand this matter
After understanding it now, I would like to know what was the result of the "placebo" irregardless of the efficacy of the placebo test
The theory behind is that patients under placebo (fake administration of the drug), should not be able to tell they are a placebo, but in this case, they are able to tell due to the color of urine.
Sometimes a placebo can have a self-induced improvement just because they believed they are taking the real drug
Posted by WinSSP > 11 minutes ago | Report Abuse Ai yo yo, TR KS ATK posted made porfeet….when Red. Profits made only when Green, faham tak? ---------------------------------------------------------
Aiyo got people really so dumb meh? Typical sour grapes la..... Smart traders bought low from 4.32 onwards. Now price still 4.49, how not to make profit? Real low average buy price mah, not those fake investor's 4.50, 4.20, 4.00, 3.50 type of auto dropping average buy price. So simple but still cannot understand? Anyway, safety first OK? Understand??? Huat Huat Huat Ah!!! $$$$$
Oh gosh, this is deep, yeah further reading the report, I see that they used MTC as a disguise I guess I'll just stick back to valuing this as a zero for now
Fierce bear market trade long also can profit. Not so simple. Precision in timing is everything. Precision timing is the best friend to the professional cha cha dancers.
ATK going to take a well deserved break. Going for a swim and drink my orange juice by the poolside.
AngTayKor may have bought low sold high Sure made profits. If bought low 4.32, sold low 4.48, profit If he bought 4.36, sold low 4.48, profit He can read stk & situation well
The way I read it, effectiveness of drug was good. Just can't reference placebo since it's not possible to create the blinded test environment. Ok la, wait for approval :)
Posted by choysun > 2 hours ago | Report Abuse The way I read it, effectiveness of drug was good. Just can't reference placebo since it's not possible to create the blinded test environment. Ok la, wait for approval :) --------------------------------------------------------
Yes the result was way below my expectations for pre-specified endpoints. But it was above my expectation that MCI patients on the average can improve cognition and functional scores. The is called disease reversal. For mild and moderate patients, able to halt the disease is within my expectation.
All the trial patients have AD (brain scanned for amyloid deposits even though Lucidity is a Tau based trial). No way AD patients can score better or stop cognition decline if the drug does not work. Under such an outcome due to TAP (Therapeutic Active Placebo) issues, any JV licensing deals with big pharmas will have to wait until Taurx finishes the extra open label 12 mth extension with all the full data. Everyone will want to be on the cautious side. As I mentioned this morning abt the 3 ways of securing regulatory approvals, I believe Taurx shd be able to secure Conditional Marketing Approval to start commercialising HMTM but the authorities will need Taurx to conduct another larger and longer duration confirmation trial.
Posted by 1invest1 > 1 hour ago | Report Abuse AngTayKor may have bought low sold high Sure made profits. If bought low 4.32, sold low 4.48, profit If he bought 4.36, sold low 4.48, profit He can read stk & situation well --------------------------------------------
It is true that ATK bought plenty at 4.32 to 4.34. None was bought at the precise low of 4.31 because my buy q at that level didnt get hit 2 weeks ago.
But ATK "safety first" this morning, plenty from opening 4.64 to 4.69. You saw those very few volume done today at 4.69? Those were sold by yours truly here. Precision charting, precision timing, dare to strike at the right moment.
Nobody knows when China will open up, but JP Morgan and Goldman Sachs predict relaxation policies by second half of 2023 (April or May at the earliest).
There's talk of opening to appease citizens cum election this 16th Oct. Too many speculations around. In anyway, the opening could actually lift the whole market sentiment
Unlikely. They would rather wait until after the "Two Sessions" some time around March 2023. Even if China decides to open next year, they would not open up at once. They may test out some cities to avoid a sudden spike in cases.
Again all these are speculations because it all depends on one very important person, and he ain't saying anything about opening up yet.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DestinyL
4,746 posts
Posted by DestinyL > 2022-10-07 09:40 | Report Abuse
I guess to some ppl glove + casino cannot coexist lol